These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22560734)

  • 1. CaRES (Contrast Echocardiography Registry for Safety Surveillance): a prospective multicenter study to evaluate the safety of the ultrasound contrast agent definity in clinical practice.
    Weiss RJ; Ahmad M; Villanueva F; Schmitz S; Bhat G; Hibberd MG; Main ML;
    J Am Soc Echocardiogr; 2012 Jul; 25(7):790-5. PubMed ID: 22560734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images.
    Kitzman DW; Goldman ME; Gillam LD; Cohen JL; Aurigemma GP; Gottdiener JS
    Am J Cardiol; 2000 Sep; 86(6):669-74. PubMed ID: 10980221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An observational study of the occurrence of serious adverse reactions among patients who receive optison in routine medical practice.
    Wei K; Shah S; Jaber WA; DeMaria A
    J Am Soc Echocardiogr; 2014 Sep; 27(9):1006-10. PubMed ID: 24930121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies.
    Kusnetzky LL; Khalid A; Khumri TM; Moe TG; Jones PG; Main ML
    J Am Coll Cardiol; 2008 Apr; 51(17):1704-6. PubMed ID: 18436124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of Definity on systemic and pulmonary hemodynamics in patients.
    Wei K; Main ML; Lang RM; Klein A; Angeli S; Panetta C; Mikati I; Lee LV; Bernstein JA; Ahmad M
    J Am Soc Echocardiogr; 2012 May; 25(5):584-8. PubMed ID: 22365709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (multicenter registry results in 4,300,966 consecutive patients).
    Main ML; Ryan AC; Davis TE; Albano MP; Kusnetzky LL; Hibberd M
    Am J Cardiol; 2008 Dec; 102(12):1742-6. PubMed ID: 19064035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of ultrasound contrast agents in current clinical practice with special focus on DEFINITY
    Salih M; Ali SM; Jena N; Ananthasubramaniam K
    Future Cardiol; 2021 Mar; 17(2):197-214. PubMed ID: 32897099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety With Echocardiographic Contrast Agents.
    Muskula PR; Main ML
    Circ Cardiovasc Imaging; 2017 Apr; 10(4):. PubMed ID: 28377467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of ultrasound enhancing agents in echocardiography.
    Kumar S; Purtell C; Peterson A; Gibbons P; Khan AM; Heitner SB
    Echocardiography; 2019 Jun; 36(6):1041-1044. PubMed ID: 31038768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: a multi-center study.
    Wever-Pinzon O; Suma V; Ahuja A; Romero J; Sareen N; Henry SA; De Benedetti Zunino M; Chaudhry FF; Suryadevara RS; Sherrid MV; Chaudhry FA
    Eur Heart J Cardiovasc Imaging; 2012 Oct; 13(10):857-62. PubMed ID: 22427401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound contrast agents: balancing safety versus efficacy.
    Main ML; Goldman JH; Grayburn PA
    Expert Opin Drug Saf; 2009 Jan; 8(1):49-56. PubMed ID: 19236217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms.
    Grayburn PA; Weiss JL; Hack TC; Klodas E; Raichlen JS; Vannan MA; Klein AL; Kitzman DW; Chrysant SG; Cohen JL; Abrahamson D; Foster E; Perez JE; Aurigemma GP; Panza JA; Picard MH; Byrd BF; Segar DS; Jacobson SA; Sahn DJ; DeMaria AN
    J Am Coll Cardiol; 1998 Jul; 32(1):230-6. PubMed ID: 9669275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of ultrasound contrast agents in stress echocardiography.
    Gabriel RS; Smyth YM; Menon V; Klein AL; Grimm RA; Thomas JD; Sabik EM
    Am J Cardiol; 2008 Nov; 102(9):1269-72. PubMed ID: 18940305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast echocardiography in Australian clinical practice.
    Hamilton-Craig C; Boga T; West C; Kelly N; Anscombe R; Burstow D; Platts D
    Heart Lung Circ; 2010 Jul; 19(7):385-94. PubMed ID: 20399141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opacification and border delineation improvement in patients with suboptimal endocardial border definition in routine echocardiography: results of the Phase III Albunex Multicenter Trial.
    Crouse LJ; Cheirif J; Hanly DE; Kisslo JA; Labovitz AJ; Raichlen JS; Schutz RW; Shah PM; Smith MD
    J Am Coll Cardiol; 1993 Nov; 22(5):1494-500. PubMed ID: 8227810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
    Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial.
    Cohen JL; Cheirif J; Segar DS; Gillam LD; Gottdiener JS; Hausnerova E; Bruns DE
    J Am Coll Cardiol; 1998 Sep; 32(3):746-52. PubMed ID: 9741522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress echocardiography with contrast for the diagnosis of coronary artery disease: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(10):1-59. PubMed ID: 23074387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion versus bolus contrast echocardiography: a multicenter, open-label, crossover trial.
    Weissman NJ; Cohen MC; Hack TC; Gillam LD; Cohen JL; Kitzman DW
    Am Heart J; 2000 Mar; 139(3):399-404. PubMed ID: 10689253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience.
    Dolan MS; Gala SS; Dodla S; Abdelmoneim SS; Xie F; Cloutier D; Bierig M; Mulvagh SL; Porter TR; Labovitz AJ
    J Am Coll Cardiol; 2009 Jan; 53(1):32-8. PubMed ID: 19118722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.